mLab / m-screen Corona Antigen Test
Simple nasal swap* or nasopharyngeal swab** / Under 30 minutes / Sensitivity 98.32%** and 97.25%* / TCID50 115 / In stock in Germany / CE IVD marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute / German Manufacturer / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
Laihe / Novel Corona Antigen Test
Nasopharyngeal swab / under 30 minutes / Sensitivity 95.07% / CE marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute and IVD / box of 100 / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
Nal von minden / dedico plus
Simple nasal swap or nasopharyngeal swab / under 30 minutes / Sensitivity 97.10% / TCID50 75.5 / CE IVD marked for diagnostic use in EU and associated countries / Paul Ehrlich Institute / box of 100 / Min order 10000 pcs / Free delivery within Germany / In stock in Germany
9736 Coranavirus Ag Rapid Test Kits Suppliers
Short on time? Let Coranavirus Ag Rapid Test Kits sellers contact you.
Brand J.Mithra
Test Kit Type HBsAg Test Kit (Rapid)
Detects All the 11 subtype of HBsAg
Sensitivity 100% by WHO Evaluation
Specificity 100% by PATH USA Evaluation
Cat. No HB010100
Intended Use : Hepacard is visual, rapid, sensitive and accurate one step immunoassay for the qualitative detection of Hepatitis B surface antigen (HBsAg) in Human serum or plasma.The assay is intended to be used as an aid in the recognition and diagnosis of acute infections and chronic infectious carriers of the Hepatitis B Virus(HBV).
Salient Features:
Detects all the 11 subtype of HBsAg.
Antigen Sensitivity- 0.5 ng/ml.
No sample preparation required.
See through Device for easy result interpretation.
Shelf life-30 months at 2-30C.
WHO Evaluated with 100% Sensitivity.
Evaluations:
PATH USA: Sensitivity 100% and Specificity 100% .
DEPT. OF CLINICAL VIROLOGY, CMC VELLORE: Sensitivity 100% and Specificity 100%
Approved By Drug Controller General Of India( DCGI) For use In Blood Banks.
For the newly discovered new coronavirus mutant strain Omicron(B.1.1.529),our conducts the sequence comparison analysis of its 32 mutation sites. All mutation sites are outside the epitope region recognized by the new crown paired monoclonal antibody selected by our company.Therefore,according to known academic opinions,the effective production strain for Omicron(B.1.1.529)can still be detected by our product"SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold Immunochromatography)"
Next,our will continue to follow up on the mutation of Covid-19perform sequence alignment analysis in timeand evaluate and verify the detection ability of key mutation sites to ensure the sensitivity and specificity of the kit.
Packing Specifications
The kit is an in vitro immunochromatographic assay for the qualitative detection of Cov19, Influenza A and Influenza B virus antigens in human nasopharyngeal, oropharyngeal swab, and salvia samples.
Cov19 is an acute respiratory infectious disease that humans are easily infected with. According to current epidemiological investigations, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main symptoms are: fever, fatigue, dry cough, in a few cases can appear nasal congestion, sore throat, myalgia and diarrhea. Influenza, often called the flu is caused by the influenza virus. It is a highly contagious viral infection of the respiratory tract that can be spread by coughing or sneezing. Influenza outbreaks occur every fall and winter. There are influenza A, B and C viruses. Influenza A viruses are more prevalent than influenza B and Cand causes more severe illness.
Cov19 infection and Influenza virus infection have similar symptoms, such as fever, cough, etc. This kit can simultaneously detect the antigens of the three viruses and provides an easy workflow, short turnaround time, and rapid diagnosis of Cov19, Influenza A and influenza B virus infections using nasopharyngeal, oropharyngeal swab or salvia samples.
The kit is an immunochromatographic assay,based on double antibody sandwich method to detect Cov19 and Influenza A/B virus antigens. This method does not require expensive medical instruments and consumables. After adding the extracted specimen to the sample well on the test cassette, Cov19, Influenza A/B virus antigens in the sample will interact with the colloidal gold-labeled anti-CoV-2 and Influenza A/B antibodies on the conjugate pads. Then the conjugate pad will release re-solubilized conjugate onto the nitrocellulose membrane. The nitrocellulose membrane (NC membrane) diffuses it forward.
As the sample moves along the device binding reagents situated on the nitrocellulose membrane bind to the target at the test line. If the sample contains a COV19 antigen, it will bind to the colloidal goldanti-CoV-2 Np monoclonal antibody, diffuse forward, and then react with the anti-CoV-2 Np monoclonal antibody immobilized on the NC membrane detection line (COV19 Test line). Similarly, if the specimen contains Influenza A/Influenza B antigens, the antigens will react with antibody-coated particles, the conjugate migrate laterally forward, and cause a colored lines (A, B linesrespectively).
9736 Coranavirus Ag Rapid Test Kits Suppliers
Short on time? Let Coranavirus Ag Rapid Test Kits sellers contact you.
